Search results
Articles 1–20. Chief Scientific Officer - Cited by 50,820 - Gene and cell therapy - genome editing - engineered DNA binding proteins.
Philip Gregory, D. Phil., Joins bluebird bio as Chief Scientific Officer. CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Jun. 15, 2015-- bluebird bio, Inc. (Nasdaq:BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and T cell-based immunotherapies, today announced that ...
View Philip Gregory’s profile on LinkedIn, a professional community of 1 billion members. Experience: Regeneron · Location: Cambridge · 500+ connections on LinkedIn.
Sep 20, 2017 · Philip D. Gregory has served as Chief Scientific Officer of bluebird bio since June 2015, a US biotech company focused on gene therapy, cancer immunotherapy and genome editing.
Associate Research Professor Centre for Cancer Biology. City West Campus (HB9-32) tel +61 8 830 27829. email Philip.Gregory@unisa.edu.au. Available for media comment. Research Degree Supervisor. About me. A/Prof Gregory leads the Gene Regulation in Cancer laboratory within the Centre for Cancer Biology.
Philippa Gregory CBE (born 9 January 1954) is an English historical novelist who has been publishing since 1987. The best known of her works is The Other Boleyn Girl (2001), which in 2002 won the Romantic Novel of the Year Award from the Romantic Novelists' Association [1] and has been adapted into two films.
Books listed in Philippa Gregory's suggest reading order. Gregory previously listed these as two separate series, the Tudor Court and Cousins' War series, but now lists them as one series.
